By selecting the Yes option, leaving Amgen.sa option you understand that you are leaving the corporate page of Amgen Saudi Arabia and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Saudi Arabia is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Saudi Arabia. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Despite progress in scientific research and available treatments and diagnostic tools, osteoporosis remains a global health problem with potentially devastating consequences for patients and significant costs for health care systems. This report, prepared by Ghent University, presents for the first time the strongest voice in the mission to increase awareness of osteoporosis and to advocate for proper diagnosis and treatment to prevent future fractures – the patients’ voice. Patients of both sexes and all ages, representing 14 countries worldwide, have shared their powerful experiences and perspectives reinforcing the need for early screening, intervention and appropriate post-fracture care. Joining the patients’ voice, Amgen calls on policymakers and health systems to prioritize integrated
people-centered osteoporosis care and elevate bone health to a national health priority to minimize the consequences of the disease.
